THE European Medicines Agency (EMA) has approved the Pfizer-BioNTech COVID-19 vaccine as a booster for children aged 12 years and older.
The EMA's human medicines committee said that the available evidence was sufficient to conclude that the immune response to a booster dose in adolescents would be at least equal to that in adults.
The EMA has also approved Moderna's vaccine for children aged six to 11 years.
The above article was sent to subscribers in Pharmacy Daily's issue from 25 Feb 22
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 25 Feb 22
